Einführung des GermanVasc. Gemeinsames gefäßregister für Deutschland

Increasing economic aspects of the healthcare system, forthcoming legislative amendments and an inhomogeneous patient population call for advanced methods of quality improvement and research in vascular medicine. More than 12 established international registry projects have proven the importance of clinical registries as a complementary method for randomized clinical trials (RCT). In the USA the restenosis rate after carotid endarterectomy (CEA) could also be decreased due to the results of register data. In the United Kingdom the mortality rate of elective surgery in 8380 patients with abdominal aortic aneurysms (AAA) has been reduced from 7,5% to 2.4% from 2008 to 2012 by the use of register data. Unlike in many other countries, Germany currently has no common population-based registry for vascular treatments. The prospective registry for AAA currently only records a small proportion of treatments. The mandatory data collection and analysis of approximately 33,000 CEAs by the AQUA Institute is an important part of quality insurance but has limitations because of the limited validity. An interdisciplinary common vascular registry for Germany, GermanVasc, allows a better and more accurate description of the actual medical care situation. With GermanVasc it will be possible to answer some of the key questions in vascular medicine in Germany.